financetom
Business
financetom
/
Business
/
Arm, Qualcomm to make closing cases in chip license dispute trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arm, Qualcomm to make closing cases in chip license dispute trial
Dec 19, 2024 4:23 AM

(Reuters) - Lawyers for Arm Holdings and Qualcomm ( QCOM ) are set to make closing arguments on Friday in a case that could upend Qualcomm's ( QCOM ) push into the PC market with a chip meant to rival Apple ( AAPL ) and Intel ( INTC ) on speed.

An eight-person jury in a U.S. federal court in Delaware will determine whether Qualcomm ( QCOM ) or Nuvia, a startup Qualcomm ( QCOM ) purchased for $1.4 billion in 2021, breached a license agreement with U.K.-based Arm, which supplies intellectual property to both firms.

If Arm is victorious, the British firm could force Qualcomm ( QCOM ) to destroy the technology it purchased from Nuvia, which has become the basis of a chip released this year that Microsoft ( MSFT ) and the entire Windows PC industry had hoped would claw back market share lost to Apple ( AAPL ).

The dispute centers on the royalties that chip companies pay on each semiconductor made using Arm's technology. Before its acquisition by Qualcomm ( QCOM ), Nuvia's license agreement required it to pay far higher royalty rates than Qualcomm ( QCOM ).

After Qualcomm ( QCOM ) bought Nuvia, it aimed to use Nuvia's technology in its chips while paying the lower royalties due under its own agreement with Arm. Arm objected, kicking off a dispute that led Arm to sue Qualcomm ( QCOM ) in 2022.

In a trial that started Monday, Arm sought to portray Qualcomm's ( QCOM ) moves as a first-of-its-kind flouting of standard contractual terms the British company had used successfully for decades and that would have upended its business model.

Qualcomm ( QCOM ), by contrast, portrayed Arm as a longtime vendor whose new CEO had ambitions to reap higher royalty rates and compete against Qualcomm ( QCOM ) by starting to design its own chip.

Documents and testimony also showed that San Diego, California-based Qualcomm ( QCOM ) estimated it could eventually save $1.4 billion per year in payments to Arm by switching to Nuvia's technology as it pushed into new markets. Its executives repeatedly testified that their plans did not violate license agreements.

The jury must determine if Qualcomm ( QCOM ) and Nuvia breached the deals and whether Arm met its obligations under the agreements.

During the trial, jurors were shown contract language that appeared to give Arm sweeping license rights to products built using its instructions, which could have implications for Arm's agreements with other chipmakers. Qualcomm ( QCOM ) executives testified that such a reading of the language ignored that its license covered the extensive design work done by Qualcomm ( QCOM ) engineers to create almost entirely new products.

A verdict in the trial, which started on Monday and was set to last five days, could come as early as Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
JPMorgan, Goldman Sachs stay in China but businesses shift
JPMorgan, Goldman Sachs stay in China but businesses shift
Oct 15, 2025
NEW YORK, Oct 15 (Reuters) - JPMorgan Chase ( JPM ) and Goldman Sachs ( GS ) are sticking with their businesses in China as escalating tensions with the U.S. loom over global markets, bank executives said on Wednesday. JPMorgan ( JPM ), the largest U.S. bank, is still investing in China even as its operations there evolve, said Vice...
Johnson & Johnson Rules Out Big Acquisitions, Reiterates Focus On Small Deals: Analyst
Johnson & Johnson Rules Out Big Acquisitions, Reiterates Focus On Small Deals: Analyst
Oct 15, 2025
On Tuesday, Johnson & Johnson ( JNJ ) reported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating the consensus of $2.75. JNJ is trading at elevated levels. See what the experts say here. Johnson & Johnson ( JNJ ) also announced plans to separate its Orthopedics business to enhance strategic and operational focus. The...
ISS recommends Staar shareholders reject Alcon's $1.5 billion offer
ISS recommends Staar shareholders reject Alcon's $1.5 billion offer
Oct 15, 2025
Oct 15 (Reuters) - Proxy advisory firm Institutional Shareholder Services on Wednesday recommended that investors in Staar Surgical ( STAA ) reject an offer by Swiss eyecare giant Alcon, putting the $1.5 billion deal in doubt. The move marks another setback to the planned takeover, which Staar's biggest shareholder has actively campaigned against. Staar shareholders are due to vote on...
BRIEF-Constellation Software'S Harris Operating Group To Acquire TECVIA Holding GmbH
BRIEF-Constellation Software'S Harris Operating Group To Acquire TECVIA Holding GmbH
Oct 15, 2025
Oct 15 (Reuters) - Constellation Software Inc ( CNSWF ): * CONSTELLATION SOFTWARE'S ( CNSWF ) HARRIS OPERATING GROUP ENTERS INTO AGREEMENT TO ACQUIRE TECVIA HOLDING GMBH Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved